Estelle Li
Impact in
- Biochemistry top 10%
- Amino Acid Enzymes and Metabolism
-
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
Papers in
-
- Epigenetics and DNA Methylation 3
- Surgery 3
- Bladder and Urothelial Cancer Treatments 3
- Tissue Engineering and Regenerative Medicine 2
- Co-authors
- Ladan Fazli (9 shared papers)Martin Gleave (4 shared papers)Qian Wang (1 shared paper)Colleen C. Nelson (1 shared paper)Yue Feng (1 shared paper)Jessamy Tiffen (1 shared paper)Charles G. Bailey (1 shared paper)Cynthia Metierre (1 shared paper)
In The Last Decade
Estelle Li
11 papers receiving 310 citations
Peers
Comparison fields: 5 of 56
- Biochemistry 69
- Cancer Research 76
- Biotechnology 28
- Oncology 78
- Molecular Biology 195
Countries citing papers authored by Estelle Li
This map shows the geographic impact of Estelle Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estelle Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estelle Li more than expected).
Fields of papers citing papers by Estelle Li
This network shows the impact of papers produced by Estelle Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estelle Li. The network helps show where Estelle Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Estelle Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 141 | |
| 2 | 2013 | 42 | |
| 3 | 2014 | 37 | |
| 4 | 2015 | 34 | |
| 5 | 2014 | 33 | |
| 6 | 2014 | 16 | |
| 7 | An Empirical Study on Cross-Border Profit Shifting in Australia | 2020 | 3 |
| 8 | 2013 | 2 | |
| 9 | The Australian Dividend Imputation System and Corporate Tax Avoidance | 2019 | 1 |
| 10 | 2013 | 1 | |
| 11 | 2013 | 1 |
About Estelle Li
Estelle Li is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Cell Biology and Economics and Econometrics, having authored 11 papers that have together received 311 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (3 papers), Epigenetics and DNA Methylation (3 papers), Prostate Cancer Treatment and Research (2 papers), Corporate Taxation and Avoidance (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Taxation and Legal Issues (2 papers), Taxation and Compliance Studies (2 papers) and Hippo pathway signaling and YAP/TAZ (1 paper). The work is most often cited by research in Biochemistry (69 citations), Cancer Research (76 citations), Biotechnology (28 citations), Oncology (78 citations) and Molecular Biology (195 citations). Estelle Li has collaborated with scholars based in Canada, Australia and Germany. Frequent co-authors include Ladan Fazli, Martin Gleave, Qian Wang, Colleen C. Nelson, Yue Feng, Jessamy Tiffen, Charles G. Bailey, Cynthia Metierre, Melanie Lehman and William Ritchie. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, PLoS ONE, Molecular Endocrinology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.